RedHill Biopharma (RDHL) Competitors $2.75 0.00 (0.00%) Closing price 03:58 PM EasternExtended Trading$2.84 +0.10 (+3.45%) As of 06:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RDHL vs. SYBX, ORGS, HCWB, BCTX, AFMD, GOVX, QNTM, MRKR, MTVA, and SPRBShould you be buying RedHill Biopharma stock or one of its competitors? The main competitors of RedHill Biopharma include Synlogic (SYBX), Orgenesis (ORGS), HCW Biologics (HCWB), BriaCell Therapeutics (BCTX), Affimed (AFMD), GeoVax Labs (GOVX), Quantum Biopharma (QNTM), Marker Therapeutics (MRKR), MetaVia (MTVA), and Spruce Biosciences (SPRB). These companies are all part of the "pharmaceutical products" industry. RedHill Biopharma vs. Synlogic Orgenesis HCW Biologics BriaCell Therapeutics Affimed GeoVax Labs Quantum Biopharma Marker Therapeutics MetaVia Spruce Biosciences Synlogic (NASDAQ:SYBX) and RedHill Biopharma (NASDAQ:RDHL) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, community ranking, dividends and earnings. Which has better earnings & valuation, SYBX or RDHL? RedHill Biopharma has higher revenue and earnings than Synlogic. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynlogic$8K1,884.52-$57.28M-$2.51-0.51RedHill Biopharma$3.71M0.95$23.92MN/AN/A Is SYBX or RDHL more profitable? RedHill Biopharma's return on equity of 0.00% beat Synlogic's return on equity.Company Net Margins Return on Equity Return on Assets SynlogicN/A -207.84% -114.81% RedHill Biopharma N/A N/A N/A Do institutionals and insiders have more ownership in SYBX or RDHL? 63.4% of Synlogic shares are owned by institutional investors. Comparatively, 7.2% of RedHill Biopharma shares are owned by institutional investors. 3.0% of Synlogic shares are owned by insiders. Comparatively, 6.8% of RedHill Biopharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community prefer SYBX or RDHL? RedHill Biopharma received 96 more outperform votes than Synlogic when rated by MarketBeat users. However, 69.54% of users gave Synlogic an outperform vote while only 66.41% of users gave RedHill Biopharma an outperform vote. CompanyUnderperformOutperformSynlogicOutperform Votes33169.54% Underperform Votes14530.46% RedHill BiopharmaOutperform Votes42766.41% Underperform Votes21633.59% Which has more risk & volatility, SYBX or RDHL? Synlogic has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500. Comparatively, RedHill Biopharma has a beta of 3.84, indicating that its share price is 284% more volatile than the S&P 500. Does the media favor SYBX or RDHL? In the previous week, RedHill Biopharma had 2 more articles in the media than Synlogic. MarketBeat recorded 3 mentions for RedHill Biopharma and 1 mentions for Synlogic. Synlogic's average media sentiment score of 1.87 beat RedHill Biopharma's score of 0.30 indicating that Synlogic is being referred to more favorably in the media. Company Overall Sentiment Synlogic Very Positive RedHill Biopharma Neutral SummaryRedHill Biopharma beats Synlogic on 8 of the 12 factors compared between the two stocks. Remove Ads Get RedHill Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RDHL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RDHL vs. The Competition Export to ExcelMetricRedHill BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.52M$6.91B$5.63B$8.10BDividend YieldN/A2.73%4.56%4.02%P/E RatioN/A7.2224.5519.02Price / Sales0.95225.58383.6492.49Price / Cash0.0165.6738.1634.64Price / Book0.076.506.954.34Net Income$23.92M$142.41M$3.20B$247.23M7 Day Performance-1.79%-3.10%-2.42%-0.71%1 Month Performance-23.61%-4.64%2.96%-3.92%1 Year Performance-99.14%-8.32%11.14%1.61% RedHill Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RDHLRedHill Biopharma0.5227 of 5 stars$2.75flatN/A-99.1%$3.52M$3.71M0.00210Short Interest ↑SYBXSynlogic1.84 of 5 stars$1.31+4.0%N/A-26.5%$15.32M$8,000.00-0.3180Positive NewsORGSOrgenesisN/A$3.15-9.0%N/AN/A$15.12M$662,000.000.00150HCWBHCW Biologics1.9342 of 5 stars$0.34-0.3%N/A-82.2%$15.10M$3.50M-0.3440Positive NewsBCTXBriaCell Therapeutics1.7569 of 5 stars$4.07+6.0%$32.00+686.2%-89.5%$15.10MN/A-0.318News CoverageGap UpAFMDAffimed4.4548 of 5 stars$0.90+2.2%$13.50+1,401.7%-84.4%$14.47M$877,000.000.00200Short Interest ↓GOVXGeoVax Labs3.0766 of 5 stars$1.50-2.6%$14.20+846.7%-25.5%$14.15M$3.09M0.0010Short Interest ↓News CoverageQNTMQuantum BiopharmaN/A$7.18+46.8%N/AN/A$13.78MN/A-0.47N/ANews CoverageGap UpHigh Trading VolumeMRKRMarker Therapeutics3.9856 of 5 stars$1.28+3.6%$13.50+954.7%-73.2%$13.71M$3.31M0.0060Short Interest ↑MTVAMetaVia2.0131 of 5 stars$1.59+7.4%$12.00+654.7%N/A$13.70MN/A0.0010Analyst RevisionPositive NewsGap UpSPRBSpruce Biosciences3.2349 of 5 stars$0.33-1.4%$2.50+656.7%-54.4%$13.65M$7.10M-0.3520Short Interest ↓Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies Synlogic Competitors Orgenesis Competitors HCW Biologics Competitors BriaCell Therapeutics Competitors Affimed Competitors GeoVax Labs Competitors Quantum Biopharma Competitors Marker Therapeutics Competitors MetaVia Competitors Spruce Biosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RDHL) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RedHill Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share RedHill Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RDHL Stock Free RDHL Stock Alerts